Jefferson Vaccine Center
A New Coronavirus Vaccine Candidate, CORAVAX™
Jefferson Vaccine Center scientists have created CORAVAX ™, a new coronavirus vaccine by adding a SARS-COV-2 component onto an existing safe and effective vaccine, with established manufacturing hubs, which could help speed global production.
The Center is dedicated to vaccine research and the related areas of immunology and microbial pathogenesis. We leverage strengths in basic and translational research in providing a forum for open discussions and a focal point in the Philadelphia area for people with these same interests.
Learn more about Jefferson clinical vaccine trials and primary care clinical trials.